Article Details
Retrieved on: 2024-06-18 15:07:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca Executive Vice President, Oncology R&D Susan Galbraith said she was "disappointed" in the CAPItello-290 outcome. Truqap is currently ...
Article found on: www.morningstar.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here